Aurobindo USA receives FTC clearance for Lannett acquisition
Aurobindo Pharma USA has received FTC clearance to acquire Lannett. The deal is expected to close before the end of June 2026.
Image: Aurobindo
WEFRA LIFE appoints Can Yildiz as Chief Innovation Officer
WEFRA LIFE is realigning its innovation setup and appointing Can Yildiz as Chief Innovation Officer for the agency group.
AbbVie to acquire Apogee and expand immunology pipeline
AbbVie plans to acquire Apogee for about $10.9 billion, adding clinical immunology assets for atopic dermatitis and asthma.
Sanofi Adds Podcast to MS-Begleiter.de
Sanofi Germany has added a podcast to MS-Begleiter.de, offering information on multiple sclerosis for patients, relatives and interested listeners.
Jason Graff named Global CCO of VML Health
VML Health appoints Jason Graff as Global Chief Creative Officer. The AREA 23 creative leader will guide its global health creative strategy.
Eva Alhnef named new business director at NiSiPharm
NiSiPharm expands its leadership team as Eva Alhnef becomes business director, bringing pharma experience and process expertise.
“America Cures” ad highlights early U.S. access to medicines
A new “America Cures” ad centers on the claim that U.S. patients receive new medicines first, highlighting access as its core message.
Martin Krämer becomes new Chief Financial Officer at CHEPLAPHARM
Martin Krämer has become CFO of CHEPLAPHARM. The former Röhm executive will oversee finance, audit, risk, treasury and investor relations.
Johnson & Johnson invests over $1 billion in Jacksonville vision operations
Johnson & Johnson will invest more than $1 billion in Jacksonville to expand ACUVUE contact lens manufacturing, packaging and distribution.
GSK to acquire Nuvalent in $10.6 billion oncology deal
GSK agreed to buy Nuvalent for $10.6 billion, adding late-stage lung cancer assets and broadening its oncology growth platform.